{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:10:43Z","timestamp":1788109843125,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005351","name":"Neurosurgery Research and Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014906","name":"Brain Injury Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014906","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veteran's Affairs","doi-asserted-by":"crossref","award":["BX004256, RX001141, RX03958, IK6BX005235"],"award-info":[{"award-number":["BX004256, RX001141, RX03958, IK6BX005235"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2010743"],"award-info":[{"award-number":["W81XWH2010743"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI56383 and AI32894"],"award-info":[{"award-number":["AI56383 and AI32894"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Germinal matrix hemorrhage is a devastating disease of pre-term infancy commonly resulting in post-hemorrhagic hydrocephalus, periventricular leukomalacia, and subsequent neurocognitive deficits. We demonstrate vascular expression of the adhesion molecule P-selectin after GMH and investigate a strategy to specifically target complement inhibition to sites of P-selectin expression to mitigate the pathological sequelae of GMH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We prepared two fusion proteins consisting of different anti-P-selectin single chain antibodies (scFv\u2019s) linked to the complement inhibitor Crry. One scFv targeting vehicle (2.12scFv) blocked the binding of P-selectin to its PSGL-1 ligand expressed on leukocytes, whereas the other targeting vehicle (2.3scFv) bound P-selectin without blocking ligand binding. Post-natal C57BL\/6\u00a0J mice on day 4 (P4) were subjected to collagenase induced-intraventricular hemorrhage and treated with 2.3Psel-Crry, 2.12Psel-Crry, or vehicle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to vehicle treatment, 2.3Psel-Crry treatment after induction of GMH resulted in reduced lesion size and mortality, reduced hydrocephalus development, and improved neurological deficit measurements in adolescence. In contrast, 2.12Psel-Crry treatment resulted in worse outcomes compared to vehicle. Improved outcomes with 2.3Psel-Crry were accompanied by decreased P-selectin expression, and decreased complement activation and microgliosis. Microglia from 2.3Psel-Crry treated mice displayed a ramified morphology, similar to na\u00efve mice, whereas microglia in vehicle treated animals displayed a more ameboid morphology that is associated with a more activated status. Consistent with these morphological characteristics, there was increased microglial internalization of complement deposits in vehicle compared to 2.3Psel-Crry treated animals, reminiscent of aberrant C3-dependent microglial phagocytosis that occurs in other (adult) types of brain injury. In addition, following systemic injection, 2.3Psel-Crry specifically targeted to the post-GMH brain. Likely accounting for the unexpected finding that 2.12Psel-Crry worsens outcome following GMH was the finding that this construct interfered with coagulation in this hemorrhagic condition, and specifically with heterotypic platelet\u2013leukocyte aggregation, which express P-selectin and PSGL-1, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GMH induces expression of P-selectin, the targeting of which with a complement inhibitor protects against pathogenic sequelae of GMH. A dual functioning construct with both P-selectin and complement blocking activity interferes with coagulation and worsens outcomes following GMH, but has potential for treatment of conditions that incorporate pathological thrombotic events, such as ischemic stroke.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-023-02828-4","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T23:27:50Z","timestamp":1686871670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage"],"prefix":"10.1186","volume":"20","author":[{"given":"Devin","family":"Hatchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alshareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Vasas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Guglietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Borucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Mallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"17","key":"2828_CR1","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3109\/14767058.2014.979783","volume":"28","author":"E Calisici","year":"2015","unstructured":"Calisici E, et al. Neurodevelopmental outcomes of premature infants with severe intraventricular hemorrhage. J Matern Fetal Neonatal Med. 2015;28(17):2115\u201320.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2828_CR2","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1542\/peds.2015-0944","volume":"136","author":"A Mukerji","year":"2015","unstructured":"Mukerji A, Shah V, Shah PS. Periventricular\/intraventricular hemorrhage and neurodevelopmental outcomes: a meta-analysis. Pediatrics. 2015;136(6):1132\u201343.","journal-title":"Pediatrics"},{"issue":"1","key":"2828_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1542\/peds.2009-2416","volume":"125","author":"M Heron","year":"2010","unstructured":"Heron M, et al. Annual summary of vital statistics: 2007. Pediatrics. 2010;125(1):4\u201315.","journal-title":"Pediatrics"},{"issue":"1","key":"2828_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jnr.24394","volume":"98","author":"D Klebe","year":"2020","unstructured":"Klebe D, et al. Posthemorrhagic hydrocephalus development after germinal matrix hemorrhage: established mechanisms and proposed pathways. J Neurosci Res. 2020;98(1):105\u201320.","journal-title":"J Neurosci Res"},{"issue":"6","key":"2828_CR5","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.3390\/ijms23062943","volume":"23","author":"M Alshareef","year":"2022","unstructured":"Alshareef M, et al. A role of complement in the pathogenic sequelae of mouse neonatal germinal matrix hemorrhage. Int J Mol Sci. 2022;23(6):2943.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2828_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41582-020-0321-y","volume":"16","author":"JK Karimy","year":"2020","unstructured":"Karimy JK, et al. Inflammation in acquired hydrocephalus: pathogenic mechanisms and therapeutic targets. Nat Rev Neurol. 2020;16(5):285\u201396.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2828_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12987-017-0083-0","volume":"14","author":"G Habiyaremye","year":"2017","unstructured":"Habiyaremye G, et al. Chemokine and cytokine levels in the lumbar cerebrospinal fluid of preterm infants with post-hemorrhagic hydrocephalus. Fluids Barriers CNS. 2017;14(1):35.","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"2828_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3109\/07853890.2010.481085","volume":"42","author":"H Kallankari","year":"2010","unstructured":"Kallankari H, et al. Chemokine CCL18 predicts intraventricular hemorrhage in very preterm infants. Ann Med. 2010;42(6):416\u201325.","journal-title":"Ann Med"},{"issue":"10","key":"2828_CR9","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1523\/JNEUROSCI.2197-17.2018","volume":"38","author":"A Alawieh","year":"2018","unstructured":"Alawieh A, et al. Identifying the role of complement in triggering neuroinflammation after traumatic brain injury. J Neurosci. 2018;38(10):2519\u201332.","journal-title":"J Neurosci"},{"issue":"46","key":"2828_CR10","doi-asserted-by":"publisher","first-page":"14319","DOI":"10.1073\/pnas.1513698112","volume":"112","author":"MM Ruseva","year":"2015","unstructured":"Ruseva MM, et al. An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice. Proc Natl Acad Sci. 2015;112(46):14319\u201324.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"2828_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.neuroscience.2008.07.015","volume":"158","author":"TV Arumugam","year":"2009","unstructured":"Arumugam TV, et al. Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience. 2009;158(3):1074\u201389.","journal-title":"Neuroscience"},{"issue":"20","key":"2828_CR12","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1523\/JNEUROSCI.2462-19.2020","volume":"40","author":"AM Alawieh","year":"2020","unstructured":"Alawieh AM, et al. Complement-dependent synaptic uptake and cognitive decline after stroke and reperfusion therapy. J Neurosci. 2020;40(20):4042\u201358.","journal-title":"J Neurosci"},{"key":"2828_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.768198","author":"A Pozo-Rodrig\u00e1lvarez","year":"2021","unstructured":"Pozo-Rodrig\u00e1lvarez A, et al. C3a receptor signaling inhibits neurodegeneration induced by neonatal hypoxic-ischemic brain injury. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.768198.","journal-title":"Front Immunol"},{"key":"2828_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108927","volume":"205","author":"J Tang","year":"2022","unstructured":"Tang J, et al. C3\/C3aR inhibition alleviates GMH-IVH-induced hydrocephalus by preventing microglia-astrocyte interactions in neonatal rats. Neuropharmacology. 2022;205: 108927.","journal-title":"Neuropharmacology"},{"issue":"3","key":"2828_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/cvr\/cvv154","volume":"107","author":"RP McEver","year":"2015","unstructured":"McEver RP. Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res. 2015;107(3):331\u20139.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"2828_CR16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.imbio.2012.07.024","volume":"217","author":"WB Gorsuch","year":"2012","unstructured":"Gorsuch WB, et al. The complement system in ischemia-reperfusion injuries. Immunobiology. 2012;217(11):1026\u201333.","journal-title":"Immunobiology"},{"issue":"18","key":"2828_CR17","doi-asserted-by":"publisher","first-page":"8378","DOI":"10.1073\/pnas.92.18.8378","volume":"92","author":"C Lozada","year":"1995","unstructured":"Lozada C, et al. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci U S A. 1995;92(18):8378\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"2828_CR18","doi-asserted-by":"publisher","first-page":"7768","DOI":"10.1016\/S0021-9258(18)83104-0","volume":"264","author":"R Hattori","year":"1989","unstructured":"Hattori R, et al. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem. 1989;264(14):7768\u201371.","journal-title":"J Biol Chem"},{"issue":"3","key":"2828_CR19","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1172\/JCI117430","volume":"94","author":"KE Foreman","year":"1994","unstructured":"Foreman KE, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest. 1994;94(3):1147\u201355.","journal-title":"J Clin Invest"},{"issue":"10","key":"2828_CR20","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.4049\/jimmunol.177.10.7266","volume":"177","author":"C Atkinson","year":"2006","unstructured":"Atkinson C, et al. Complement-dependent P-selectin expression and injury following ischemic stroke. J Immunol. 2006;177(10):7266\u201374.","journal-title":"J Immunol"},{"issue":"6","key":"2828_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20041497","volume":"201","author":"I Del Conde","year":"2005","unstructured":"Del Conde I, et al. Platelet activation leads to activation and propagation of the complement system. J Exp Med. 2005;201(6):871\u20139.","journal-title":"J Exp Med"},{"key":"2828_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785229","author":"C Zheng","year":"2021","unstructured":"Zheng C, et al. Characterization of novel P-selectin targeted complement inhibitors in murine models of hindlimb injury and transplantation. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.785229.","journal-title":"Front Immunol"},{"issue":"9","key":"2828_CR23","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.4049\/jimmunol.160.9.4553","volume":"160","author":"RJ Quigg","year":"1998","unstructured":"Quigg RJ, et al. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol. 1998;160(9):4553\u201360.","journal-title":"J Immunol"},{"issue":"3","key":"2828_CR24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nprot.2006.170","volume":"1","author":"RMJ Deacon","year":"2006","unstructured":"Deacon RMJ. Assessing nest building in mice. Nat Protoc. 2006;1(3):1117\u20139.","journal-title":"Nat Protoc"},{"issue":"1","key":"2828_CR25","doi-asserted-by":"crossref","first-page":"8.5C.1","DOI":"10.1002\/0471142301.ns0805cs27","volume":"27","author":"JM Wehner","year":"2004","unstructured":"Wehner JM, Radcliffe RA. Cued and contextual fear conditioning in mice. Curr Protoc Neurosci. 2004;27(1):8.5C.1-8.5C.14.","journal-title":"Curr Protoc Neurosci"},{"key":"2828_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.20059","author":"AJ Harrington","year":"2016","unstructured":"Harrington AJ, et al. MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.20059.","journal-title":"Elife"},{"issue":"2","key":"2828_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jneumeth.2004.04.029","volume":"139","author":"K T\u00fcreyen","year":"2004","unstructured":"T\u00fcreyen K, et al. Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J Neurosci Methods. 2004;139(2):203\u20137.","journal-title":"J Neurosci Methods"},{"issue":"5","key":"2828_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003395","volume":"9","author":"D Nayak","year":"2013","unstructured":"Nayak D, et al. Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system. PLoS Pathog. 2013;9(5): e1003395.","journal-title":"PLoS Pathog"},{"issue":"18","key":"2828_CR29","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1161\/01.CIR.0000017140.26466.F5","volume":"105","author":"JE Freedman","year":"2002","unstructured":"Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation. 2002;105(18):2130\u20132.","journal-title":"Circulation"},{"issue":"4","key":"2828_CR30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1365-2125.2011.03906.x","volume":"72","author":"G Passacquale","year":"2011","unstructured":"Passacquale G, Ferro A. Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs homotypic aggregation. Br J Clin Pharmacol. 2011;72(4):604\u201318.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"2828_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3171\/2014.11.PEDS14364","volume":"15","author":"JAE Radic","year":"2015","unstructured":"Radic JAE, Vincer M, McNeely PD. Outcomes of intraventricular hemorrhage and posthemorrhagic hydrocephalus in a population-based cohort of very preterm infants born to residents of Nova Scotia from 1993 to 2010. J Neurosurg Pediatr PED. 2015;15(6):580\u20138.","journal-title":"J Neurosurg Pediatr PED"},{"issue":"8","key":"2828_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/nm.4361","volume":"23","author":"JK Karimy","year":"2017","unstructured":"Karimy JK, et al. Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus. Nat Med. 2017;23(8):997\u20131003.","journal-title":"Nat Med"},{"issue":"6","key":"2828_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/14728222.2020.1752182","volume":"24","author":"JK Karimy","year":"2020","unstructured":"Karimy JK, Reeves BC, Kahle KT. Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury. Expert Opin Ther Targets. 2020;24(6):525\u201333.","journal-title":"Expert Opin Ther Targets"},{"issue":"10","key":"2828_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/cns.13144","volume":"25","author":"S-P Liu","year":"2019","unstructured":"Liu S-P, et al. Secukinumab attenuates reactive astrogliosis via IL-17RA\/(C\/EBP\u03b2)\/SIRT1 pathway in a rat model of germinal matrix hemorrhage. CNS Neurosci Ther. 2019;25(10):1151\u201361.","journal-title":"CNS Neurosci Ther"},{"key":"2828_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao6459","author":"A Alawieh","year":"2018","unstructured":"Alawieh A, Langley EF, Tomlinson S. Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice. Sci Transl Med. 2018. https:\/\/doi.org\/10.1126\/scitranslmed.aao6459.","journal-title":"Sci Transl Med."},{"issue":"1","key":"2828_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-021-01179-6","volume":"9","author":"K Mallah","year":"2021","unstructured":"Mallah K, et al. Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury. Acta Neuropathol Commun. 2021;9(1):72.","journal-title":"Acta Neuropathol Commun"},{"issue":"7638","key":"2828_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"11","key":"2828_CR38","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/art.40219","volume":"69","author":"JM Thurman","year":"2017","unstructured":"Thurman JM, Frazer-Abel A, Holers VM. The evolving landscape for complement therapeutics in rheumatic and autoimmune diseases. Arthritis Rheumatol. 2017;69(11):2102\u201313.","journal-title":"Arthritis Rheumatol"},{"key":"2828_CR39","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220752","author":"A Java","year":"2023","unstructured":"Java A, Kim AHJ. The role of complement in autoimmune disease-associated thrombotic microangiopathy and the potential for therapeutics. J Rheumatol. 2023. https:\/\/doi.org\/10.3899\/jrheum.220752.","journal-title":"J Rheumatol."},{"key":"2828_CR40","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.10.014","author":"DS Genest","year":"2022","unstructured":"Genest DS, et al. Renal thrombotic microangiopathy: a review. Am J Kidney Dis. 2022. https:\/\/doi.org\/10.1053\/j.ajkd.2022.10.014.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2828_CR41","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.clp.2008.07.014","volume":"35","author":"HJ McCrea","year":"2008","unstructured":"McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol. 2008;35(4):777\u201392, vii.","journal-title":"Clin Perinatol."},{"issue":"1","key":"2828_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.jp.7210590","volume":"22","author":"BH Morris","year":"2002","unstructured":"Morris BH, et al. Patterns of physical and neurologic development in preterm children. J Perinatol. 2002;22(1):31\u20136.","journal-title":"J Perinatol"},{"issue":"1","key":"2828_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-3782(86)90164-7","volume":"14","author":"W Szymonowicz","year":"1986","unstructured":"Szymonowicz W, et al. Neurodevelopmental outcome of periventricular haemorrhage and leukomalacia in infants 1250 g or less at birth. Early Human Dev. 1986;14(1):1\u20137.","journal-title":"Early Human Dev"},{"issue":"4","key":"2828_CR44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1542\/peds.98.4.719","volume":"98","author":"AH Whitaker","year":"1996","unstructured":"Whitaker AH, et al. Neonatal cranial ultrasound abnormalities in low birth weight infants: relation to cognitive outcomes at six years of age. Pediatrics. 1996;98(4):719\u201329.","journal-title":"Pediatrics"},{"issue":"2","key":"2828_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jtcvs.2004.06.048","volume":"129","author":"S Keshavjee","year":"2005","unstructured":"Keshavjee S, et al. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg. 2005;129(2):423\u20138.","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02828-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:30:43Z","timestamp":1702600243000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02828-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2828"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02828-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2617965\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles and approval by the Institutional Animal Care and Use Committee at the Medical University of South Carolina.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflicts reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}